Any person with a smartphone can screen him- or herself for treatment-relevant atrial fibrillation - the world's most important arrhythmia. This could have huge impact on the prevention of stroke.

In this interview, Axel Bauer MD and Thomas F. Deering MD, FACC, with Sun Moon Kim MD, FSCAI, FACC, discuss ESC Late-Breaker: eBRAVE-AF: Smartphone-based AF screening.

Related References:

1. Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial
2. Rationale and design of a digital trial using smartphones to detect subclinical atrial fibrillation in a population at risk: The eHealth-based bavarian alternative detection of Atrial Fibrillation (eBRAVE-AF) trial

Clinical Topics: Arrhythmias and Clinical EP

Keywords: ACCELLite

< Back to Listings